• Something wrong with this record ?

Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory response

J. Mares, P. Richtrova, A. Hricinova, Z. Tuma, J. Moravec, D. Lysak, M. Matejovic

. 2010 ; 4 (10-11) : 829-838.

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

PURPOSE: dialysis-induced inflammatory response including leukocyte and complement activation is considered a significant cofactor of chronic morbidity in long-term hemodialysis (HD) patients. The aim of this study was to provide better insight into its molecular background. EXPERIMENTAL DESIGN: in 16 patients, basic biocompatibility markers, i.e. leukocyte counts and C5a levels, were monitored during HD on a polysulfone membrane. Proteins adsorbed to dialyzers were eluted and separated by 2-DE. Selected proteins were identified by MS; ficolin-2 plasma levels were assessed. Data are given as medians (quartile ranges). RESULTS: in total, 7.2 (34.7) mg proteins were retrieved from dialyzer eluates and were resolved into 217 protein spots. The proteins most enriched in eluates (and hence selectively adsorbed) were those involved in complement activation (C3c, ficolin-2, mannan-binding lectin serine proteases, properdin) and cell adhesion (actin, caldesmon, tropomyosin, vitronectin, vinculin). A significant decrease of plasma ficolin-2 (41% [4.7], p<0.001) was evidenced during one HD session, associated with leukopenia (r=0.73, p=0.001) and C5a production (r=-0.62, p=0.01) at 15 min. CONCLUSIONS AND CLINICAL RELEVANCE: ficolin-2 adsorption to polysulfone dialyzer initiates the lectin pathway of complement activation, mediates dialysis-induced leukopenia, and results in a significant depletion of ficolin-2, an essential component of innate immunity.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027236
003      
CZ-PrNML
005      
20160329165218.0
007      
ta
008      
120816s2010 gw f 000 0#eng||
009      
AR
024    7_
$a 10.1002/prca.201000031 $2 doi
035    __
$a (PubMed)21137026
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Mareš, Jan, $u Department of Internal Medicine I, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic. mares@fnplzen.cz; Proteomic Laboratory, Charles University Medical School, Plzen, Czech Republic $d 1971- $7 xx0106581
245    10
$a Proteomic profiling of blood-dialyzer interactome reveals involvement of lectin complement pathway in hemodialysis-induced inflammatory response / $c J. Mares, P. Richtrova, A. Hricinova, Z. Tuma, J. Moravec, D. Lysak, M. Matejovic
520    9_
$a PURPOSE: dialysis-induced inflammatory response including leukocyte and complement activation is considered a significant cofactor of chronic morbidity in long-term hemodialysis (HD) patients. The aim of this study was to provide better insight into its molecular background. EXPERIMENTAL DESIGN: in 16 patients, basic biocompatibility markers, i.e. leukocyte counts and C5a levels, were monitored during HD on a polysulfone membrane. Proteins adsorbed to dialyzers were eluted and separated by 2-DE. Selected proteins were identified by MS; ficolin-2 plasma levels were assessed. Data are given as medians (quartile ranges). RESULTS: in total, 7.2 (34.7) mg proteins were retrieved from dialyzer eluates and were resolved into 217 protein spots. The proteins most enriched in eluates (and hence selectively adsorbed) were those involved in complement activation (C3c, ficolin-2, mannan-binding lectin serine proteases, properdin) and cell adhesion (actin, caldesmon, tropomyosin, vitronectin, vinculin). A significant decrease of plasma ficolin-2 (41% [4.7], p<0.001) was evidenced during one HD session, associated with leukopenia (r=0.73, p=0.001) and C5a production (r=-0.62, p=0.01) at 15 min. CONCLUSIONS AND CLINICAL RELEVANCE: ficolin-2 adsorption to polysulfone dialyzer initiates the lectin pathway of complement activation, mediates dialysis-induced leukopenia, and results in a significant depletion of ficolin-2, an essential component of innate immunity.
650    _2
$a adsorpce $7 D000327
650    _2
$a lektinová dráha komplementu $7 D037582
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a lidé $7 D006801
650    _2
$a zánět $x imunologie $x metabolismus $7 D007249
650    _2
$a lektiny $x chemie $x metabolismus $7 D037102
650    _2
$a membrány umělé $7 D008567
650    _2
$a polymery $x chemie $x metabolismus $7 D011108
650    _2
$a proteom $x analýza $7 D020543
650    _2
$a dialýza ledvin $x přístrojové vybavení $x metody $7 D006435
650    _2
$a sulfony $x chemie $x metabolismus $7 D013450
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Richtrová, Pavlína, $d 1975- $7 xx0074467 $u Department of Internal Medicine I, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic
700    1_
$a Hričinová, Alena $7 xx0121635 $u Department of Internal Medicine I, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic
700    1_
$a Tůma, Zdeněk, $d 1980- $7 xx0128863 $u Proteomic Laboratory, Charles University Medical School, Plzen, Czech Republic
700    1_
$a Moravec, Jiří, $d 1976- $7 xx0128805 $u Proteomic Laboratory, Charles University Medical School, Plzen, Czech Republic
700    1_
$a Lysák, Daniel $7 xx0105598 $u Department of Hematology, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic
700    1_
$a Matějovič, Martin, $d 1969- $7 nlk20030138334 $u Department of Internal Medicine I, Charles University Medical School and Teaching Hospital, Plzen, Czech Republic
773    0_
$w MED00157628 $t Proteomics. Clinical applications $x 1862-8354 $g Roč. 4, č. 10-11 (2010), s. 829-838
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21137026 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20160329164940 $b ABA008
999    __
$a ok $b bmc $g 949278 $s 784582
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 4 $c 10-11 $d 829-838 $i 1862-8354 $m Proteomics. Clinical applications $n Proteomics Clin Appl $x MED00157628
LZP    __
$b NLK112 $a Pubmed-20120816/11/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...